Manitou Investment Management Ltd. increased its stake in CME Group Inc. (NASDAQ:CME) by 33.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 166,221 shares of the company’s stock after buying an additional 42,010 shares during the period. CME Group accounts for approximately 5.1% of Manitou Investment Management Ltd.’s holdings, making the stock its 4th largest position. Manitou Investment Management Ltd.’s holdings in CME Group were worth $16,190,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Geode Capital Management LLC boosted its stake in shares of CME Group by 6.0% in the first quarter. Geode Capital Management LLC now owns 2,947,602 shares of the company’s stock valued at $282,588,000 after buying an additional 167,225 shares in the last quarter. Primecap Management Co. CA boosted its stake in shares of CME Group by 6.5% in the first quarter. Primecap Management Co. CA now owns 1,946,113 shares of the company’s stock valued at $186,924,000 after buying an additional 118,150 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of CME Group by 2.0% in the first quarter. Legal & General Group Plc now owns 1,391,482 shares of the company’s stock valued at $133,643,000 after buying an additional 27,322 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in shares of CME Group by 4.6% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,137,234 shares of the company’s stock valued at $110,767,000 after buying an additional 50,334 shares in the last quarter. Finally, Bank of Montreal Can bought a new stake in shares of CME Group during the second quarter valued at about $35,643,000. Institutional investors own 79.89% of the company’s stock.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Shares of CME Group Inc. (NASDAQ:CME) traded up 0.35% during mid-day trading on Tuesday, reaching $104.09. 637,943 shares of the company’s stock were exchanged. CME Group Inc. has a 1-year low of $81.87 and a 1-year high of $110.35. The company’s 50 day moving average is $106.42 and its 200 day moving average is $99.82. The stock has a market capitalization of $35.27 billion, a PE ratio of 26.29 and a beta of 0.83.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The company earned $906 million during the quarter, compared to the consensus estimate of $897.84 million. During the same quarter in the previous year, the firm earned $0.95 earnings per share. The firm’s quarterly revenue was up 10.5% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post $4.43 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were paid a $0.60 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.31%. CME Group’s dividend payout ratio is currently 60.61%.

CME has been the topic of several research reports. Deutsche Bank AG raised their target price on shares of CME Group from $111.00 to $112.00 and gave the stock a “buy” rating in a report on Friday, August 5th. Jefferies Group restated a “buy” rating and issued a $118.00 target price on shares of CME Group in a report on Thursday, October 13th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $99.00 to $106.00 and gave the stock an “overweight” rating in a report on Friday, July 29th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, June 30th. Finally, Credit Agricole SA dropped their price target on shares of CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a research note on Thursday, July 14th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $103.27.

In other CME Group news, insider Bryan T. Durkin sold 14,990 shares of the firm’s stock in a transaction that occurred on Wednesday, September 28th. The shares were sold at an average price of $105.10, for a total transaction of $1,575,449.00. Following the sale, the insider now owns 66,936 shares of the company’s stock, valued at $7,034,973.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Kimberly S. Taylor sold 2,300 shares of the firm’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $102.58, for a total transaction of $235,934.00. Following the sale, the insider now directly owns 103,789 shares in the company, valued at approximately $10,646,675.62. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.